Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
TwXYf3Q5WkaNp1YV